Focus on hepatocellular carcinoma

Cancer Cell

Volumn 5, Issue 3, 2004, Pages 215-219

  Bruix, Jordi ^a   Boix, Loreto ^a   Sala, Margarita ^a   Llovet, Josep M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; CARCINOGEN; CISPLATIN; DOXORUBICIN; HEPATITIS B VACCINE; INTERFERON; MYCOTOXIN; RIBAVIRIN; TAMOXIFEN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CHEMOEMBOLIZATION; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; EARLY DIAGNOSIS; ECHOGRAPHY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY LOSS; HUMAN; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER SURGERY; LIVER TRANSPLANTATION; META ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEX RATIO; TREATMENT OUTCOME; TUMOR VASCULARIZATION; VACCINATION; VIRUS CARCINOGENESIS; VIRUS CARRIER; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 1642544603     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(04)00058-3     Document Type: Review

References (22)

1. Block T.M., Mehta A.S., Fimmel C.J., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 22:2003;5093-5107.
2. Bolondi L., Sofia S., Siringo S., Gaiani S., Casali A., Zironi G., Piscaglia F., Gramantieri L., Zanetti M., Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma. A cost-effectiveness analysis Gut. 48:2001;251-259.
3. Borzio M., Fargion S., Borzio F., Fracanzani A.L., Croce A.M., Stroffolini T., Oldani S., Cotichini R., Roncalli M. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J. Hepatol. 39:2003;208-214.
4. Buendia M.A. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 10:2000;185-200.
5. Burrel M., Llovet J.M., Ayuso C., Iglesias C., Sala M., Miquel R., Caralt T., Ayuso J.R., Sole M., Sanchez M.et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation. Hepatology. 38:2003;1034-1042.
6. Camma C., Giunta M., Andreone P., Craxi A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis. An evidence-based approach J. Hepatol. 34:2001;593-602.
7. Chang M.-H., Chen C.-J., Lai M.-S., Hsu H.-M., Wu T.-C., Kong M.-S., Liang D.-C., Shau W.-Y., Chen D.-S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:1997;1855-1859.
8. Evans A.A., Chen G., Ross E.A., Shen F.M., Lin W.Y., London W.T. Eight-year follow-up of the 90,000-person Haimen City cohort. I. Hepatocellular carcinoma mortality, risk factors, and gender differences Cancer Epidemiol. Biomarkers Prev. 11:2002;369-376.
9. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F.L. Jr., Haussinger D., Diago M., Carosi G., Dhumeaux D.et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:2002;975-982.
10. Hsu H.C., Jeng Y.M., Mao T.L., Chu J.S., Lai P.L., Peng S.Y. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am. J. Pathol. 157:2000;763-770.
11. Laurent-Puig P., Legoix P., Bluteau O., Belghiti J., Franco D., Binot F., Monges G., Thomas G., Bioulac-Sage P., Zucman-Rossi J. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 20:2001;1763-1773.
12. Llovet J.M., Burroughs A., Bruix J. Hepatocellular Carcinoma. Lancet. 362:2003;1907-1917.
13. Nakashima Y., Nakashima O., Tanaka M., Okuda K., Nakashima M., Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol. Res. 26:2003;142-147.
14. Paradis V., Bieche I., Dargere D., Laurendeau I., Laurent C., Bioulac Sage P., Degott C., Belghiti J., Vidaud M., Bedossa P. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach. determination of a molecular diagnostic index Am. J. Pathol. 163:2003;733-741.
15. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden. GLOBOCAN 2000 Int. J. Cancer. 94:2001;153-156.
16. Pollicino T., Squadrino G., Cerenzia G., Cacciola I., Raffa G., Craxi A., Farinati F., Missale G., Smedile A., Tiribelli C.et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 126:2004;102-110.
17. Prieto M., Berenguer M., Rayon J.M., Cordoba J., Arguello L., Carrasco D., Garcia-Herola A., Olaso V., De Juan M., Gobernado M.et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation. relationship with rejection episodes Hepatology. 29:1999;250-256.
18. Smith M.W., Yue Z.N., Geiss G.K., Sadovnikova N.Y., Carter V.S., Boix L., Lazaro C.A., Rosenberg G.B., Bumgarner R.E., Fausto N.et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res. 63:2003;859-864.
19. Staib F., Hussain S.P., Hofseth L.J., Wang X.W., Harris C.C. TP53 and liver carcinogenesis. Hum. Mutat. 21:2003;201-216.
20. Theise N.D., Park Y.N., Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin. Liver Dis. 6:2002;497-512.
21. Thorgeirsson S., Grisham J. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31:2002;339-346.
22. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., Hsiao C.K., Chen P.J., Chen D.S., Chen C.J. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 347:2002;168-174.